&quot;and the pharma company actually felt a significant drain in revenue, they may decide not to license the manufacture of these drugs in India at lower prices&quot;<p>But thats the thing. There will be no drain in revenue as they make money in the US by selling for $84K while they make money from the sales in India as well due to licensing agreement (albeit a bit less revenue).<p>Overall, still a pretty good deal for these pharma companies if you ask me otherwise why would they even do such a deal with India ?